 Kura Oncology NASDAQ:KURA was upgraded by BidaskClub from a sell rating to a hold rating in a report issued on Wednesday, BidAskClub reports. Several other equities research analysts also recently issued reports on KURA. Piper Sandler cut their target price on shares of Kura Oncology from 32.00 to 30.00 in a research note on Wednesday, ... 